Pancreatic Cancer Research

ResearcherUniversity of IndonesiaNo recent work listed

Marcellus Simadibrata K

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0003-1131-5836; OpenAlex author ID A5010639085. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. The Expressions of NF-κB, COX-2, Sp1, and c-Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient Survival. First author DOI 10.3390/pathophysiology30020009↗
  2. Screening of pancreatic cancer: Target population, optimal timing and how? Last author DOI 10.1016/j.amsu.2022.104814↗
  3. Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis. First author DOI 10.5152/tjg.2021.211106↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kaka Renaldi · 2 shared papers, 2021–2023 · strength 0.30
  2. Andy William · 2 shared papers, 2021–2023 · strength 0.30
  3. Dadang Makmun · 2 shared papers, 2021–2023 · strength 0.30
  4. Andrew Waleleng · 1 shared paper, 2022 · strength 0.15
  5. Bradley Jimmy Waleleng · 1 shared paper, 2022 · strength 0.15
  6. Randy Adiwinata · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.